Abstract 1050: Extended treatment with azacitidine maintains low DNMT1 levels and DNA methylation in MDA-MB-231 cells in vitro and in vivo

Autor:	Kyle J. MacBeth, Aaron N. Nguyen, Zeen Tong, Antonio Luna-Moran, Brian Melo, Quinton Tieu
Rok vydání:	2012
Předmět:	Cancer Research Azacitidine Phases of clinical research Cancer Biology Pharmacology medicine.disease In vitro Oncology Apoptosis In vivo DNA methylation medicine medicine.drug DNA hypomethylation
Zdroj:	Cancer Research. 72:1050-1050
ISSN:	1538-7445 0008-5472
Popis:	Background: Azacitidine (AZA) is approved for treatment of patients with myelodysplastic syndromes or WHO-defined acute myeloid leukemia with multi-lineage dysplasia ( Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1050. doi:1538-7445.AM2012-1050
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::47a30692d83340b607f84b02a9168231 https://doi.org/10.1158/1538-7445.am2012-1050 Zobrazit plný text záznamu